Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

US Patent 8278455 · Granted Oct 2, 2012

Estimated economic value: $65,904,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting formulations2024
Mono- or di-substituted indole derivatives as dengue viral replication inhibitor2024
PZA and cytochrome Bc1 inhibitor combination treatment2024
Mono- or di-substituted indole derivatives as dengue viral replication inhibitor2023
Substituted indoline derivatives as dengue viral replication inhibitors2023
Substituted indoline derivatives as dengue viral replication inhibitors2023
Substituted indoline derivatives as dengue viral replication inhibitors2023
Macrocyclic deaza-purinones for the treatment of viral infections2023
Macrocyclic deaza-purinones for the treatment of viral infections2023
Macrocyclic deaza-purinones for the treatment of viral infections2023
Macrocyclic deaza-purinones for the treatment of viral infections2023
Substituted indoline derivatives as dengue viral replication inhibitors2022